跳至主要内容
临床试验/NCT06079125
NCT06079125已完成不适用

Type of Surgical Intervention for Chiari Malformation-syringomyelia: a Multicenter Randomized Controlled Study

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2024年1月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
250
试验地点
1
主要终点
improvement or resolution of the syrinx,

研究概览

简要总结

The purpose of this study is to determine whether a posterior fossa decompression and duraplasty with or without tonsil manipulation results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomyelia.

详细描述

Participants with Chiari Malformation type I and syringomyelia will be randomized to either have a posterior fossa decompression and duraplasty with or without tonsil manipulation. The participant will then return to the neurosurgeon's office at the following time points which are consistent with standard of care practice: 3-6 months, 12 and 24 months. At these visits, the clinician will complete a physical exam and the participant will report on the prognosis of symptoms and complete questionnaires. A spine MRI will be performed 3-6 months, 12 and 24 months after the surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
14 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥14 years old
  • Chiari malformation type I ≥5 mm tonsillar ectopia
  • a syrinx with a width > 50% of the cross-sectional diameter of the spinal cord , and a length of at least 2 cervical and/or thoracic vertebral segments.
  • MRI of the brain and cervical and thoracic spine are required prior to surgery and must be available to be shared with the Data Coordinating Center

排除标准

  • included one or more of the following preexisting conditions: hydrocephalus; tumor; brain trauma; stroke; meningitis; abscess;
  • other congenital anomalies of the brain or skull base; vertebral anomalies (i.e., Klippel-Feil, atlas assimilation, etc.);
  • degenerative or demyelinating disease;
  • CM-I without syringomyelia;
  • syringomyelia with cerebellar tonsils in a normal position;
  • fibromyalgia;
  • chronic fatigue syndrome;
  • prior posterior fossa surgery.
  • Unable to share pre-decompression MRI of the brain and spine Patients who do not wish to participate

研究组 & 干预措施

Posterior fossa decompression with duraplasty

Experimental

In brief, a midline incision was made from the inion to the C2 level. A piece of autologous fascia was harvested from the muscular fascia layer. Paraspinal muscles were dissected to expose the occipital bone, posterior arch of the atlas and axis, spinous process, and lamina. The inferior portion of the occipital bone and approximately 2 cm of the posterior arch of C1 were removed, achieving bony decompression (approximately 2.5-3 × 2.5-3 cm). Once the dura was exposed, the atlanto-occipital membrane was coagulated and dissected off the dura. The dura was then incised in a Y-shaped fashion, with care taken to preserve the underlying arachnoid. Watertight duraplasty was performed using the autologous fascia. The wound was closed in anatomical layers.

干预措施: Posterior fossa decompression with duraplasty (Procedure)

PFDD with tonsillar resection/reduction

Experimental

Briefly, a midline incision approximately 3-4 cm posterior to the foramen magnum is made. The incision is deepened layer by layer along the midline to reach the occipital bone, exposing the posterior margin of the foramen magnum and part of the occipital squama. The posterior edge of the foramen magnum is opened, and part of the occipital squama is removed up to the junction of the cerebellar vermis and cerebellar tonsils. The occipitoatlantal fascia is exposed and dissected. The dura mater and arachnoid mater are incised longitudinally and suspended bilaterally to provide a clear surgical field. The primary objectives of resection were: ensuring no significant obstruction of CSF circulation at the foramen magnum and the foramen of Magendie under natural conditions. Preventing occlusion of the foramen of Magendie caused by herniated cerebellar tonsils or any membranous structures under natural conditions. The dura is closed in situ.

干预措施: PFDD with tonsillar resection/reduction (Procedure)

结局指标

主要结局

improvement or resolution of the syrinx,

时间窗: 3-6, 12 and 24 months

defined as \> 50% improvement in length, maximal cross-sectional diameter, or both.

次要结局

  • complication rates(12 months)
  • blood loss(12 months)
  • hospital stay(12 months)
  • cost for the hospitalisation.(12 months)
  • Chicago Chiari Outcome Scale (CCOS) scale(12 months)
  • visual analog scale (VAS)(12 months)
  • Japanese Orthopaedic Association (JOA) scale(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验